ArticleInflammopharmacology2026
Diphenyleneiodonium exhibits protective effects against both nociception and gastrointestinal inflammation in vivo.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- N-Acetylcysteine, Tiron, and Their Combination: In Vitro Antioxidant and Anti-Inflammatory Activities and Their Protective Effect in a Rat Model of Acetic Acid-Induced Ulcerative Colitis.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Reactive oxygen species (ROS) and nitrogen-derived oxidants, such as nitric oxide (NO), are produced by immune cells through the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) and nitric oxide synthases (NOS), respectively. These pro-oxidants disrupt physiological homeostasis, contributing to hyperalgesia, the excessive release of inflammatory markers and oxidative stress during ulcerative colitis (UC). Consequently, diphenyleneiodonium chloride (DPI), an inhibitor of NOXs and NOS, could be effective in alleviating visceral pain and UC. This study examines the antioxidant and analgesic properties of DPI, as well as its ability to modulate oxidative stress and pro-inflammatory responses in UC. The antioxidant properties of DPI and its ability to bind free iron were determined using ABTS and DPPH tests, as well as a ferrous iron chelating capacity assay. DPI's analgesic activity was investigated using a 0.6% acetic acid (AA) mouse model of hyperalgesia, and its preventive effects against UC were determined using a 3% AA rat model of UC. Our results demonstrate that DPI limits free radicals, chelates ferrous iron and reduces writhing number (Wn) by p < 0.001, confirming its analgesic activity. Furthermore, intraperitoneal administration of DPI (100 ng/kg) protected rats from UC by repairing large-scale colonic damage, lowering oxidative stress by decreasing NO levels and restoring antioxidant enzymatic activities in colonic tissue. DPI also lowers plasmatic C-reactive protein (C-RP), NO content, lactate dehydrogenase (LDH) and γ-glutamyl transferase (γ-GT) activity during colitis. Therefore, targeting NOXs and NOS with DPI could be a promising strategy for treating inflammatory diseases such as colitis.
Indexed as
Identifiers
41324847What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.